Promoter holding
64.27%
CP
Charisma Pharmaceuticals Pvt Ltd - Due diligence report
A 360° intelligence report on Charisma Pharmaceuticals Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth an…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Charisma Pharmaceuticals Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records54/100
Trust Score
Moderate
Charisma Pharmaceuticals Pvt Ltd is assessed as Moderate with a Trust Score of 54/100. Charisma Pharmaceuticals Pvt Ltd is a private limited indian non-government company incorporated in 1989, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.
Report generated on 08 Oct 2026 from the latest processed filings. Charisma Pharmaceuticals Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
54/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreCaution Indicated
25/100
No active directors on record.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
No processed financialsFinancial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: N/A No Data
- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 45/100 Caution Indicated
- Company status is "Strike Off" - not Active.
- No balance-sheet filing date on record.
05
Director Intelligence
Stability score: 25/100No active directors on record.
06
Ownership & Group Intelligence
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 65
Growth signals & trust indicators
Operating for 37+ years.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Adverse company status: Strike Off.
Compliance score is weak (45/100).
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence54/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
Banker assessment20/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view34/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 1 events24 Feb 1989
Incorporated
Registered with Roc Guwahati
10
Key Observations
Auto-generated from the data aboveNot enough data yet to generate observations.
| Company | CIN | Location |
|---|---|---|
| OHM INFRA SOLUTIONS LLP | ABZ-0683 | Kamrup, Assam |
| Jwadder Beverages (Opc) Private Limited | U15400AS2019OPC019210 | Kamrup, Assam |
| Lotus Formulations & Bio-Medics Private Limited | U51900AS2011PTC010425 | Kamrup, Assam |
| Al Hallal Multitrade And Consulting Private Limited | U51909AS2010PTC009796 | Kamrup, Assam |
| Nedel Techsolutions Private Limited | U47219AS2024PTC026273 | Kamrup, Assam |
| HARDSHIP BUILDCON LLP | AAZ-7657 | Kamrup, Assam |
| Inkubiz Services Private Limited | U74999AS2019PTC019316 | Kamrup, Assam |
| Algorizon Business Venture Private Limited | U74999AS2018PTC018607 | Kamrup, Assam |
| Mahabahu Realtors Private Limited | U70101AS2011PTC010751 | Kamrup, Assam |
| Xetu Naturals Asia Private Limited | U01409AS2021PTC022213 | Kamrup, Assam |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Charisma Pharmaceuticals Pvt Ltd before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Charisma Pharmaceuticals Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Charisma Pharmaceuticals Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 54/100, distress signals and MSME payment-delay disclosures - know whether Charisma Pharmaceuticals Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Charisma Pharmaceuticals Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Charisma Pharmaceuticals Pvt Ltd an active company?
Charisma Pharmaceuticals Pvt Ltd has MCA status “Strike Off” with a compliance score of 45/100 (Caution Indicated).
Is Charisma Pharmaceuticals Pvt Ltd financially healthy?
Processed financial statements are not yet available for Charisma Pharmaceuticals Pvt Ltd, so its financial health is unassessed.
Should I do business with Charisma Pharmaceuticals Pvt Ltd?
Its overall Trust Score is 54/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Charisma Pharmaceuticals Pvt Ltd?
See the directors and ownership sections above for board and shareholding detail.
Does Charisma Pharmaceuticals Pvt Ltd have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Charisma Pharmaceuticals Pvt Ltd up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 45/100 (Caution Indicated).
Is it risky to lend to Charisma Pharmaceuticals Pvt Ltd?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
